Obalon US Commercial Registry

计划入组 1,343 人 · 首次发布于 2018 年 9 月 28 日

Obalon Balloon System Post-Approval Study

计划入组 201 人 · 首次发布于 2018 年 6 月 26 日

Obalon in Children With Severe Obesity

计划入组 10 人 · 首次发布于 2014 年 5 月 13 日

AT101,AbClon

Obesity(Abalone)

Diabetes(Abalone)

OBALON THERAPEUTICS, INC.

United States

ReShape Lifesciences

United States

OXAGON

India

ReShape Lifesciences Achieves Early EU MDR Certification for Obesity Treatment Devices

ReShape Lifesciences' Diabetes Neuromodulation Device Shows Promise in Preclinical Studies

ReShape Lifesciences Announces Merger with Vyome and Asset Sale to Biorad Amid Q1 2025 Financial Results